Status:

NOT_YET_RECRUITING

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

Lead Sponsor:

Roberto Valente

Conditions:

Pancreatic Cancer Metastatic to Liver

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive cancer and may become the second leading cause of cancer death by 2030. About half of the patients are diagnosed late, when the cancer has ...

Detailed Description

Pancreatic cancer is rapidly becoming a medical emergency. Its prognosis continues to worsen and it is projected to become the second leading cause of cancer-related deaths by 2030. At diagnosis, app...

Eligibility Criteria

Inclusion

  • Individuals with newly diagnosed pancreatic cancer in the head of the pancreas causing compression on the bile duct.
  • Metastatic stage to the liver
  • Histologically or cytologically confirmed mPDAC.
  • Cancer burden limited to maximum 5 metastases in the liver, each of them maximum 1 cm in the larger diameter.
  • Patients must be under palliative chemotherapy treatment.
  • Cancer should be radiologically measurable (in an area not previously irradiated).
  • WHO performance status 0-2.
  • Age 18-85 years.

Exclusion

  • Intellectual disability, unwillingness or language difficulties
  • which hinders the ability to give informed consent.
  • Ongoing extensive immunosuppression and/or severe leuko- or
  • thrombocytopenia.
  • Ongoing acute cholangitis.
  • Ongoing sepsis.
  • Acute kidney failure.
  • Uncompensated heart failure or unstable coronary insufficiency
  • (symptomatic/uncompensated).
  • Pregnancy or breastfeeding.
  • Any metastases outside the liver.
  • Cardiac pacemakers/cardioverter defibrillators.
  • Severe coagulopathy.

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

178 Patients enrolled

Trial Details

Trial ID

NCT07191418

Start Date

September 1 2025

End Date

September 1 2027

Last Update

September 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Surgery, Umeå University Hospital

Umeå, Sweden, 90185